Main Menu
Menu

TRIPS Waiver

Publish Date
Resources
Letters
C4IP Letter to President Biden on Covid-19 IP Waiver Proposal

Dear President Biden, We are writing to urge you to oppose the World Trade Organization’s proposed waiver of intellectual property rights for...

Press Releases
Council for Innovation Promotion Statement on ITC TRIPS Waiver Report
Yesterday, the United States International Trade Commission published its report on a possible TRIPS waiver expansion. Frank Cullen, executive director of the...
News
Prizes in place of Rx patents not the cure needed

A recent bipartisan request for funding of a study on replacing U.S. drug patents with cash prizes is just one more symptom...

BioWorld
News
C4IP Report Urges Pro-IP Rights Agenda to Counteract U.S. Innovation Stagnation

On July 11, the Council for Innovation Promotion (C4IP) released a policy report advocating for a pro-innovation legislative and administrative agenda to...

IPWatchdog
Op-Eds
The Biden administration is endangering intellectual property rights

Waiving IP protections will do nothing to help patients when there is no longer a health emergency.

...
Dallas Morning News
BlogFact Checks
An Expanded TRIPS Waiver is Unnecessary

Claim: On March 29, the International Trade Commission held a hearing on the World Trade Organization’s (WTO) proposed suspension of Covid-19 therapeutic...

Resources
Public Comments
C4IP Written Submission for Inv. No. 332-596
News
WHO pushes for more access to COVID-19 drugs
BioWorld
Resources
Issue Briefs
C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities

Dear Commissioners, On behalf of the Council for Innovation Promotion, I appreciate the opportunity to provide supplemental information following my March 29...

Resources
Public Comments
C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
News
Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
IPWatchdog
News
WTO divided over expanding COVID-19 IP waiver
BioWorld
Resources:

Resources:

C4IP Letter to President Biden on Covid-19 IP Waiver Proposal,

12/04/2023
Press Releases:

Press Releases:

Council for Innovation Promotion Statement on ITC TRIPS Waiver Report,

10/18/2023
News:

News:

Prizes in place of Rx patents not the cure needed,

08/14/2023
News:

News:

C4IP Report Urges Pro-IP Rights Agenda to Counteract U.S. Innovation Stagnation,

07/11/2023
Op-Eds:

Op-Eds:

The Biden administration is endangering intellectual property rights,

06/20/2023
Fact Checks:

Blog, Fact Checks:

An Expanded TRIPS Waiver is Unnecessary,

05/03/2023
Resources:

Resources:

C4IP Written Submission for Inv. No. 332-596,

04/26/2023
News:

News:

WHO pushes for more access to COVID-19 drugs,

04/11/2023
Resources:

Resources:

C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023
Resources:

Resources:

C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023
News:

News:

Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing,

03/29/2023
News:

News:

WTO divided over expanding COVID-19 IP waiver,

12/16/2022
Scroll to Top